Neurogene Inc. Income Tax Expense
Neurogene Inc. (NGNE) reported Income Tax Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-03-24
- Neurogene Inc. income tax expense (benefit) for the quarter ending 2014-12-31 was $222.00, a 404.55% increase year-over-year.
- Neurogene Inc. income tax expense (benefit) for the quarter ending 2014-09-30 was -$222.00.
- Neurogene Inc. income tax expense (benefit) for the quarter ending 2013-12-31 was $44.00.
- Neurogene Inc. income tax expense (benefit) for the quarter ending 2013-09-30 was -$5.04K.
- Neurogene Inc. income tax expense (benefit) for fiscal 2025 was $0.00.
- Neurogene Inc. income tax expense (benefit) for fiscal 2024 was $0.00.
- Neurogene Inc. income tax expense (benefit) for fiscal 2016 was $0.00.
- Neurogene Inc. income tax expense (benefit) for fiscal 2015 was $0.00.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed | Income Tax Expense (Benefit) 123 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-24 | |||||
| 2024-12-31 | $0.00 10-K · filed 2026-03-24 | |||||
| 2016-12-31 | $0.00 10-K · filed 2017-03-09 | |||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-09 | |||||
| 2014-12-31 | $222.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $0.00 derived: sum of 2 quarters · filed 2017-03-09 | $0.00 10-K · filed 2017-03-09 | -$222.00 10-K · filed 2015-03-16 | ||
| 2014-09-30 | -$222.00 10-Q · filed 2014-11-04 | -$222.00 10-Q · filed 2014-11-04 | ||||
| 2014-03-31 | -$3.15M 10-Q · filed 2014-05-13 | |||||
| 2013-12-31 | $44.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$5.00K derived: sum of 2 quarters · filed 2016-03-14 | -$5.00K 10-K · filed 2016-03-14 | -$5.04K 10-K · filed 2015-03-16 | ||
| 2013-09-30 | -$5.04K 10-Q · filed 2014-11-04 | -$5.04K 10-Q · filed 2014-11-04 | ||||
| 2012-12-31 | $42.29K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |